期刊文献+

帕金森病肠道起源学说的研究进展 被引量:6

Update on the theory of intestinal origin of Parkinson′s disease
原文传递
导出
摘要 帕金森病是一种以α-突触核蛋白异常聚集为特征的中枢神经系统退行性变。近年有研究发现,帕金森病可能起源于肠道。在帕金森病前驱期患者肠道中发现了异常聚集的α-突触核蛋白,动物模型提示异常聚集的α-突触核蛋白可通过迷走神经传播到中枢神经系统。帕金森病患者肠道渗透性增加、肠道氧化应激水平升高与α-突触核蛋白在肠道聚集并向中枢传播有关。 Parkinson′s disease (PD) is a progressive degenerative disease of the central nervous system, which is characterized by the aggregation of alpha-synuclein. Accumulating evidence suggests that PD may arise in the gut. Aggregation of alpha-synuclein was found in the enteric nervous system of patients with prodromal stage of PD, alpha-synuclein might spread from the enteric nervous system to the central nervous system through vagus nerve based on animal model. The increased permeability and oxidative stress of gut may also be associated with the aggregation of alpha-synuclein and its propagation from gut to the central nerve system.
作者 王东旭 冯涛 Wang Dongxu;Feng Tao(Department of Neurology, Beijing Tiantan Hospital Affiliated to Capital Medical University, Beijing 100070, China)
出处 《中华神经科杂志》 CAS CSCD 北大核心 2019年第4期349-352,共4页 Chinese Journal of Neurology
关键词 帕金森病 迷走神经 Α突触核蛋白 肠道菌群 Parkinson disease Vagus nerve alpha-Synuclein Gut flora
  • 相关文献

参考文献1

二级参考文献18

  • 1Ross GW, Abbott RD, Petrovitch H, et al. Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience [J]. Parkinsonism Relat Disord, 2012, 18 (Suppl 1 ) : S199- 202. DOI : 10. 1016/S1353-8020( 11 )70062-1.
  • 2Berg D, Godau J, Seppi K, et al. The PRIPS study: screening battery for subjects at risk for Parkinson' s disease [ J ]. Eur J Neurol, 2013, 20(1) : 102-108. DOI: 10. 1111/j. 1468-1331. 2012. 03798. x.
  • 3Gaenslen A, Wurster I, Brockmann K, et al. Prodromal features for Parkinson's disease-baseline data from the TREND study[ J]. EurJ Neurol, 2014, 21 (5): 766-772. DOI: 10. 1111/ene. 12382.
  • 4Siderowf A, Jennings D, Eberly S, et al. Impaired olfaetion and other prodromal features in the Parkinson At-Risk Syndrome Study [J]. Mov Disord, 2012, 27(3) : 406-412. DOI: 10. 1002/mds. 24892.
  • 5Jennings D, Siderowf A, Stern M, et al. Evaluating the natural history of prodromal PD in the PARS cohort [ J ]. Mov Disord, 2016, 31 ( Suppl 2) :S387.
  • 6Parkinson Progression Marker Initiative. The Parkinson Progression Marker Initiative (PPMI) I J]. Prog Neurobiol, 2011, 95 (4) : 629-635. DOI: 10. 1016/j. pneurobio. 2011.09. 005.
  • 7Noyce AJ, Bestwick JP, Silveira-Moriyama L, et al. PREDICT- PD: identifying risk of Parkinson's disease in the community: methods and baseline results [ J] 2014. 85(1), 31-37. DOI, 10 J Neurol Neurosurg Psychiatry, 1136/innn-2013-305420.
  • 8Schrag A, Horsfall L, Waiters K, et al. Prediagnostic presentations of Parkinson's disease in primary care: a case- control study[J]. Lancet Neurol, 2015, 14( 1 ) : 57-64. DO/: 10. 1016/S1474-4422 ( 14 ) 70287-X.
  • 9Berg D, Postuma RB, Adler CH, et al. MDS research criteria for prodromal Parkinson's disease [ J]. Mov Disord, 2015, 30 (12) : 1600-1611. DOI: 10. 1002/mds. 26431.
  • 10Mablknecht P, Gasperi A, Willeit P, et al. Prodromai Parkinson's disease as defined per MDS research criteria in the general elderly community [ J]. Mov Disord, 2016 June 6. Epub ahead of print. DOI: 10. 1002/mds. 26674.

同被引文献108

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部